Tata Steel sold 3.85 million shares of Tata Motors for Rs. 1,250.69 crore to reduce its debt of over Rs. 70,000 crore. Technical analysis recommends selling Tata Steel between Rs. 228-230 and buying Jubilant Life Sciences between Rs. 336-338. Asian markets declined on Monday tracking Wall Street's fall on Friday due to uncertainty around the US Federal Reserve's interest rate decision and an FBI investigation into Malaysia's 1MDB state fund.

1. SEBI Certified – Research Analyst www.choiceindia.com
Global View
India Update
Today’s Event/ Stock in News
Tata Steel said it sold 3,85,20,801 equity shares of Tata Motors to institutional investors over the stock exchange for a total
consideration of Rs 1,250.69 crore. This stake sale move is in keeping with the company's plan to sell some its cross holding in all other
Tata Group companies. However, this action was taken for the reduction in its huge debt of more than Rs 70,000 crore. In FY15, its
interest cost was Rs 4,847.75 crore, 11.7 percent higher compared to previous year.
Technical Outlook : On daily chart, stock has given downside breakout of its consolidation range (range of 244-231), in which it had been
trading for 6 days. Furthermore, stock has given close below its daily reversal value which stood at 230.60. Momentum indicator RSI
reading is at 45.90 with negative crossover which point out for negative breath in the stock. Based on the above technical parameters,
stock looking weak on daily chart. so for trading perspective, one could Sell in the range of 228-230 for the Target of 223 with SL of
232.50
Jubilant Life Sciences has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration
(US FDA) for Zolmitriptan Orally Disintegrating Tablets, 2.5 mg and 5 mg, the generic version of Zomig-ZMT (of Astra Zeneca), which is
used for acute treatment of migraine headaches in adults. As on June 30, 2015, the company had a total of 815 filings for formulations
of which 389 have been approved in various regions globally. This includes 72 ANDAs filed in the US, of which 38 have been approved
and 46 Dossier filings in Europe. Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in
manufacture and supply of APIs, Solid Dosage Formulations, Specialty Pharmaceuticals and Life Science Ingredients.
Technical Outlook: On daily chart, stock has managed to close above its daily reversal value which stands at 330, which shows that stock is
in uptrend and further upside move can be seen from present level. Beside, stock has formed bullish Harami candlestick which is bullish
reversal sign and indicating for upside movement. Momentum indicator RSI reading is at 57.65 with positive crossover, which point out
for positive breath in the stock. For trading perspective, one could Buy in the range of 336-338 for the Target of 345 with the SL of 332.
TATASTEEL
JUBILANT
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Morning Tea
21st Sept 2015
Buy in the range of 336-338 for the Target of 345 with the SL of 332
Sell in the range of 228-230 for the Target of 223 with the SL of 232.50
Globally, the Fed uncertainty irked global investors; there was sell-off on Wall Street on Friday as the Dow plunged almost 300
points. European markets to tanked 1-3 percent on Friday. Treasury yields in US extended Thursday’s decline, with 10-year note
yields around 2.13 percent. Meanwhile in Greece, voters return Alexis Tsipras to power with a strong mandate. A new
government is expected to be formed within 3 days. Tsipras thanked his supporters and said that the hard work begins now. US
averages finished sharply lower last Friday, with the Dow Jones Industrial Average closing down 1.7 % at 16384.58. The S&P 500
and Nasdaq Composite lost 1.6% closed at 1958.03 and 1.4% closed at 4827.23 percent respectively.
Asian stocks declined early Monday, tracking an uninspiring lead from Wall Street, Japanese, Hangsand and other Asian stocks
snapped a three-day winning streak on Friday after the Federal Reserve kept interest rates at a record low, raising worries about
the health of both the U.S. and global economies. Meanwhile, investors could also eye developments in Malaysia after the US
Federal Bureau of Investigation (FBI) launched an investigation into allegations of money-laundering at Malaysian state fund
1MDB, the Wall Street Journal reported on Sunday citing an unidentified source. The Shanghai Composite index traded at 0.10%
to 3100.99, Hang Seng index traded at -1.19 % to 21662.62, Japan's benchmark Nikkei 225 index traded at -2.00% to 18070.21,
South Korea's Kospi index up marginally by -1.64 % to 1963.68 levels. The SGX Nifty suggests a negative opening for our markets
as it is trading at 7909, down by 59 points.

2. SEBI Certified – Research Analyst www.choiceindia.com
Bulk Deal
Corporate Action / Result Calendar
SEBI Certified – Research Analyst www.choiceindia.com
Morning Tea
21st Sept 2015
Security in Ban
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Corporate Action:
Gayatri Projects Limited; Annual General Meeting/ Dividend - Re 1/- Per Share
HBL Power Systems Limited; Annual General Meeting / Dividend - Re 0.20/- Per Share
Godfrey Phillips India Limited; Annual General Meeting/ Dividend - Rs 8/- Per Share
Credit Analysis And Research Limited; Annual General Meeting/ Dividend - Rs 8/- Per Share
Navneet Education Limited; Annual General Meeting/ Dividend - Rs 2.20/- Per Share
Fineotex Chemical Limited; Annual General Meeting/ Dividend - Re 0.10/- Per Share (Dividend Rate Revised)
Monte Carlo Fashions Limited; Annual General Meeting/Dividend - Rs 10/- Per Share
Hi-Tech Gears Limited; Annual General Meeting/ Dividend - Rs 1.50/- Per Share
Noida Toll Bridge Company Limited; Annual General Meeting/ Dividend - Re 1/- Per Share
Gujarat Fluorochemicals Limited; Annual General Meeting/Dividend - Rs 3.50/- Per Share
Kalpataru Power Transmission Limited; Annual General Meeting/ Dividend - Rs 1.50/- Per Share
Pratibha Industries Limited; Annual General Meeting/ Dividend - Re 0.20/- Per Share
NMDC Limited; Annual General Meeting/ Dividend - Rs 1.30/- Per Share
Energy Development Company Limited; Annual General Meeting/Dividend Re 0.50 Per Share
Mirza International Limited; Annual General Meeting/ Dividend - Re 0.50/- Per Share
Jagsonpal Pharmaceuticals Limited; Annual General Meeting/ Dividend - Re 0.10/- Per Share
Indowind Energy Limited; Annual General Meeting (Book Closure Dates Revised)
Liberty Shoes Limited; Annual General Meeting / Dividend Rs 1.50/- Per Share
Prakash Steelage Limited; Annual General Meeting/Dividend Re 0.50 Per Share
Sudar Industries Limited; Annual General Meeting (Book Closure Dates Revised)
ADF Foods Limited; Annual General Meeting/ Dividend - Rs 1.50/- Per Share
Sr.No Deal Date Security Code Security Name Client Name Deal Type Quantity Price
1 18/09/2015 500570 TATAMOTORS TATA STEEL LIMITED S 38,520,801 324.68
2 18/09/2015 500570 TATAMOTORS CITIGROUP GLOBAL MARKETS MAURITIUS PRIVATE LIMITED B 20,824,918 324.50
3 18/09/2015 505192 SMLISUZU AXIS MUTUAL FUND S 210,406 1125.11
4 18/09/2015 505192 SMLISUZU NATWEST BANK PLC AS TRUSTEE OF THE JUPITER INDIA FUND B 144,786 1125.00
5 18/09/2015 535657 OONE BHARATBHAI GOPALBHAI BAROT S 110,750 8.93
6 18/09/2015 535657 OONE BHARATBHAI GOPALBHAI BAROT B 110,750 8.93
7 18/09/2015 535657 OONE HARISHKUMAR BHAGWANDAS PRAJAPATI S 110,750 8.93
8 18/09/2015 535657 OONE HARISHKUMAR BHAGWANDAS PRAJAPATI B 110,750 8.93
9 18/09/2015 535657 OONE RAJ KUMAR BAID KUMAR BAID B 100,000 8.97
10 18/09/2015 535657 OONE JAINESH S RAVAL B 87,580 8.97
CENTURYTEX

3. SEBI Certified – Research Analyst www.choiceindia.com
Contact Us
www.choiceindia.com
www.choiceindia.comcustomercare@choiceindia.com
Disclaimer
This is solely for information of clients of Choice Broking and does not construe to be an investment advice. It is also not intended as an offer or solicitation for the purchase and sale of any financial
instruments. Any action taken by you on the basis of the information contained herein is your responsibility alone and Choice Broking its subsidiaries or its employees or associates will not be liable in
any manner for the consequences of such action taken by you. We have exercised due diligence in checking the correctness and authenticity of the information contained in this recommendation, but
Choice Broking or any of its subsidiaries or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the
information contained in this recommendation or any action taken on basis of this information. Technical analysis studies market psychology, price patterns and volume levels. It is used to forecast
future price and market movements. Technical analysis is complementary to fundamental analysis and news sources. The recommendations issued herewith might be contrary to recommendations
issued by Choice Broking in the company research undertaken as the recommendations stated in this report is derived purely from technical analysis. Choice Broking has based this document on
information obtained from sources it believes to be reliable but which it has not independently verified; Choice Broking makes no guarantee, representation or warranty and accepts no responsibility
or liability as to its accuracy or completeness. The opinions contained within the report are based upon publicly available information at the time of publication and are subject to change without
notice. The information and any disclosures provided herein are in summary form and have been prepared for informational purposes. The recommendations and suggested price levels are intended
purely for trading purposes. The recommendations are valid for the day of the report however trading trends and volumes might vary substantially on an intraday basis and the recommendations may
be subject to change. The information and any disclosures provided herein may be considered confidential. Any use, distribution, modification, copying, forwarding or disclosure by any person is
strictly prohibited. The information and any disclosures provided herein do not constitute a solicitation or offer to purchase or sell any security or other financial product or instrument. The current
performance may be unaudited. Past performance does not guarantee future returns. There can be no assurance that investments will achieve any targeted rates of return, and there is no guarantee
against the loss of your entire investment.
POTENTIAL CONFLICT OF INTEREST DISCLOSURE (as on date of report) Disclosure of interest statement – • Analyst interest of the stock /Instrument(s): - No. • Firm interest of the stock /
Instrument (s): - No.
SEBI Certified – Research Analyst www.choiceindia.com
Research Team
Mr. Sumeet Bagadia Associate Director
Kunal Parmar Research Associate
Ritesh Patel Research Associate
Amit Pathania Research Associate
Vikas Chaudhari Research Associate
Rajnath Yadav Research Associate
Satish Kumar Research Associate
Morning Tea
21st Sept 2015
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Kunal Parmar
Digitally signed by Kunal Parmar
DN: cn=Kunal Parmar, o=Choice Equity Broking
Pvt Ltd., ou=Research Dept.,
email=kunal.parmar@choiceindia.com, c=IN
Date: 2015.09.21 08:33:11 +05'30'